Most GLP-1 medications can be used in chronic kidney disease, but exenatide products should be avoided when eGFR is below 30 mL/min/1.73m
Individuals with conditions impairing B12 absorption, such as pernicious anemia or gastrointestinal disorders
The growth in the forecast period can be attributed to growing obesity population, expanding approval for cardiovascular risk reduction, innovation in oral and combination therapies, increased penetration in emerging markets, rising patient preference for weight loss benefits
Folks on immunosuppressants, anti-coagulants, or hormonal therapies require careful review because peptides can affect these medications
Vitamin B 12 fact sheet for health professionals
On the flip side, the drugs can cause gastrointestinal problems including diarrhea, constipation, nausea and vomiting